Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (1.516)

11

Tocilizumab for refractory post-COVID-19 pansclerotic morphea

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Saraswat, N. | Tripathy, D. | Mishra, A. | +3

12

Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma : TRAVERSE Continuation Study

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Maspero, J. | Peters, A. | Chapman, K. | +12

13

Real-world effectiveness of dupilumab in patients with asthma : Findings from the US ADVANTAGE study

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2024

von Blaiss, M. | Bleecker, E. | Jacob-Nara, J. | +9

14

Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London : a retrospective cohort study

enthalten in: BMJ open respiratory research | 2024

von Drysdale, M. | Galimov, E. | Yarwood, M. | +11

15

Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls

enthalten in: The Journal of rheumatology | 2024

von Eviatar, T. | Furer, V. | Polachek, A. | +14

16

Tocilizumab treatment in COVID-19 patients : therapy's side effects and effect on mortality

enthalten in: European review for medical and pharmacological sciences | 2024

von Ayvat, P. | Kayhan Omeroglu, S.

17

Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 : Evidence from the US National COVID Cohort Collaborative (N3C)

enthalten in: Clinical drug investigation | 2024

von Bell, C. | Bobbili, P. | Desai, R. | +9

18

COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab

enthalten in: American journal of hematology | 2024

von Fattizzo, B. | Röth, A. | Broome, C. | +4

19

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge

enthalten in: Scientific reports | 2024

von Chesdachai, S. | Rivera, C. | Cole, K. | +6

20

Kinetics of Trisulfide-to-Disulfide Conversion of Therapeutic IgG1 Monoclonal Antibodies Under Physiological Conditions : A Case Study of Casirivimab And Imdevimab

enthalten in: Journal of pharmaceutical sciences | 2024

von Zhong, X. | Gao, L. | Kleinberg, A. | +5